How does methylprednisolone sodium succinate injection work?
Methylprednisolone sodium succinate is a corticosteroid that acts as an anti-inflammatory and immunosuppressive agent. It works by influencing gene expression to decrease the production of inflammatory mediators and increase the production of anti-inflammatory proteins. This leads to a reduction in swelling, redness, and pain associated with inflammation, and suppresses the immune system's response [1].
What are the common side effects of this injection?
Commonly reported adverse reactions include:
* Cardiovascular effects: hypertension, edema, and thrombophlebitis [1].
* Gastrointestinal effects: peptic ulcer with possible perforation and hemorrhage, pancreatitis, esophagitis, and abdominal distention [1].
* Metabolic effects: negative nitrogen balance due to protein catabolism, hyperglycemia, and glycosuria [1].
* Neurologic and ocular effects: convulsions, increased intracranial pressure, vertigo, headache, psychic disturbances, acne, and impaired wound healing [1].
* Dermatologic effects: urticaria or other allergic manifestations [1].
* Endocrine effects: suppression of growth in children [1].
* Injection site reactions: pain, irritation, and rare instances of infection or sterile abscess [1].
Are there serious risks associated with methylprednisolone sodium succinate?
Serious adverse reactions can occur, including hypersensitivity reactions and anaphylactoid reactions. Physicians should be prepared for immediate treatment of such reactions [1]. Patients may experience electrolyte imbalances, such as hypokalemia and hypochloremic alkalosis, as well as steroid myopathy [1].
When is patent exclusivity for methylprednisolone sodium succinate expected to expire?
Information regarding specific patent exclusivity timelines for methylprednisolone sodium succinate is not available in the provided text. However, DrugPatentWatch.com tracks patent and exclusivity data for pharmaceuticals [2].
Who manufactures methylprednisolone sodium succinate?
Several pharmaceutical companies manufacture methylprednisolone sodium succinate. These include, but are not limited to, Pfizer Inc. (as Depo-Medrol) and various generic manufacturers [1, 3].
What are the alternatives to methylprednisolone sodium succinate injection?
Alternative treatments depend on the specific condition being treated. Other corticosteroids, both injectable and oral, are available. Non-steroidal anti-inflammatory drugs (NSAIDs) may be used for milder inflammatory conditions, and specific immunosuppressants are used for autoimmune diseases [4].
How is methylprednisolone sodium succinate administered?
Methylprednisolone sodium succinate can be administered intramuscularly, intravenously, or intra-articularly [1]. The route of administration is determined by the condition being treated and the desired onset and duration of action.
What patient populations need special consideration when using this medication?
Special precautions are necessary for patients with certain medical conditions, including ocular herpes simplex, tuberculosis, nonspecific ulcerative colitis, diverticulitis, fresh intestinal anastomoses, abscess or other pyogenic infections, renal insufficiency, hypertension, osteoporosis, and myasthenia gravis [1]. Particular caution is advised in pregnant or lactating women and in children due to potential growth suppression [1].
Sources:
1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=631c41e5-11c5-4424-a1a3-1f81753777b1
2. https://drugpatentwatch.com/
3. https://www.pfizer.com/
4. https://www.mayoclinic.org/